Biblio Discovery — Demo Discovery Service

7 hasil untuk "Filip Baert"

Menampilkan 1–7 · 0,77 detik · RSS

  1. Artikel Jurnal

    Infective Endocarditis in Disseminated Streptococcus dysgalactiae Infection Originating From Hitherto Undetected Colorectal Adenocarcinoma

    Roel Meeus; Lander Bacquaert; Filip Baert dkk.

    Case Reports in Infectious Diseases, Vol. 2026 · 2026 · Inggris · DOAJ

    A 60-year-old woman presented with polyarthritis in the aftermath of an upper respiratory tract infection. Further investigation revealed infective mitral valve endocarditis necessitating acute surgical valve replacement due to Streptococcus dysgalactiae, as evidenced by positive blood and…

  2. Artikel Jurnal

    Multi-stakeholder validation of an evidence-based core set of quality indicators for IBD in Belgium

    Liselotte Fierens; Frank E. Rademakers; Peter Bossuyt dkk.

    BMC Health Services Research, Vol. 26 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Introduction Quality indicators assess and can improve care. Previous efforts used different methods to identify quality indicators for inflammatory bowel disease (IBD) care in Belgium. This study aimed to critically evaluate these efforts and establish a validated, multi-stakeholder…

  3. Artikel Jurnal

    The efficacy and safety of etrasimod as a first-line advanced therapy for ulcerative colitis: prespecified and post hoc subgroup data from the ELEVATE UC clinical program

    David T. Rubin; Charlie W. Lees; Filip Baert dkk.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · Inggris · DOAJ Scopus

    Background: Many patients show inadequate response or intolerance to conventional therapies for ulcerative colitis (UC), including 5-aminosalicylates (5-ASA), thiopurines, and corticosteroids (CS). Etrasimod is an oral, once daily (QD), selective sphingosine 1-phosphate (S1P) receptor modulator for…

  4. Artikel Jurnal Teks lengkap

    Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

    William J. Sandborn; Severine A.R.A. Vermeire; Laurent Peyrin‐Biroulet dkk.

    The Lancet · 2023 · Inggris · OpenAlex

    BACKGROUND: , is in development for the treatment of immune-mediated diseases, including ulcerative colitis. In these two phase 3 trials, we aimed to evaluate the safety and efficacy of etrasimod in adult patients with moderately to severely active ulcerative colitis. METHODS: In two independent…

  5. Artikel Jurnal

    Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes Mellitus

    Constance Carels; Lucas Wauters; An Outtier dkk.

    Frontiers in Pediatrics, Vol. 9 · 2021 · Inggris · DOAJ Scopus

    Background and Aims: The management of chronic inflammatory bowel diseases in youth is challenging. We aimed to determine health literacy (HL), quality of life (QoL) and clinical outcomes in young adults from the BELgian CROhn's disease registry (BELCRO) in comparison to type 1 diabetes mellitus…